Mozambique strengthens regulation of medicines and imported vaccines, boosting health protection - World Health Organization (WHO)

ViiV Healthcare press releaseViiV Healthcare announced an agreement appointing Axmed as a non-exclusive distributor to enable procurement and supply of ViiV Healthcare HIV medicines in more than 50 middle-income countries, subject to applicable local regulatory requirements. This agreement aims to offer a simpler route to access more choice in HIV care to support countries’ HIV response. Axmed is a technology-enabled business-to-business platform that connects healthcare procurers in low- and middle-income countries with suppliers to provide access to medicines. Through their technological solutions, local governments and healthcare institutions in these countries will be able to lower procurement costs and deliver efficient logistics supporting their healthcare systems to stretch resources further and reach more people. Read the full press release here.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.